G. Storm
- Biomaterials top 0.2%
- Nanoparticle-Based Drug Delivery 51
- Pharmaceutical Science top 0.5%
- Molecular Biology top 2%
- RNA Interference and Gene Delivery 38
- Advanced biosensing and bioanalysis techniques 15
- Biomedical Engineering top 2%
-
- Monoclonal and Polyclonal Antibodies Research 16
- Radiopharmaceutical Chemistry and Applications 12
-
- Orthopedic Infections and Treatments 14
-
- Immunotherapy and Immune Responses 13
-
- Chemotherapy-induced cardiotoxicity and mitigation 10
- Co-authors
- Wim E. HenninkTwan LammersDaan J.A. CrommelinChristien OussorenFabian KießlingSilvio AimeRaymond M. SchiffelersOtto C. Boerman
- Journals
- International Journal of Pharmaceutics (17 papers)Journal of Controlled Release (16 papers)Biochimica et Biophysica Acta (BBA) - Biomembranes (6 papers)
- Partner nations
- NetherlandsGermanySingapore
In The Last Decade
G. Storm
135 papers receiving 6.0k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Biomaterials 2.5k
- Pharmaceutical Science 589
- Molecular Biology 2.8k
- Biomedical Engineering 1.5k
- Radiology, Nuclear Medicine and Imaging 781
Countries citing papers authored by G. Storm
This map shows the geographic impact of G. Storm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Storm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Storm more than expected).
Fields of papers citing papers by G. Storm
This network shows the impact of papers produced by G. Storm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Storm. The network helps show where G. Storm may publish in the future.
Co-authorship network
The 25 scholars most cited alongside G. Storm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 0 | |
| 3 | 2021 | 43 | |
| 4 | 2015 | 1 | |
| 5 | 2015 | 52 | |
| 6 | 2011 | 39 | |
| 7 | 2011 | 30 | |
| 8 | 2008 | 429 | |
| 9 | 2006 | 101 | |
| 10 | 2003 | 95 | |
| 11 | 2001 | 60 | |
| 12 | 2001 | 36 | |
| 13 | 2000 | 1 | |
| 14 | 2000 | 12 | |
| 15 | Detection of infection and inflammation with technetium-99m-labeled PEG-liposomes | 1999 | 1 |
| 16 | 1999 | 9 | |
| 17 | 1997 | 28 | |
| 18 | 1996 | 26 | |
| 19 | 1993 | 101 | |
| 20 | 1993 | 41 |
About G. Storm
G. Storm is a scholar working on Biomaterials, Pharmaceutical Science, Radiology, Nuclear Medicine and Imaging, Immunology and Allergy and Immunology, having authored 137 papers that have together received 6.2k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (51 papers), RNA Interference and Gene Delivery (38 papers), Monoclonal and Polyclonal Antibodies Research (16 papers), Advanced biosensing and bioanalysis techniques (15 papers), Orthopedic Infections and Treatments (14 papers), Immunotherapy and Immune Responses (13 papers), Radiopharmaceutical Chemistry and Applications (12 papers) and Chemotherapy-induced cardiotoxicity and mitigation (10 papers). The work is most often cited by research in Biomaterials (2.5k citations), Pharmaceutical Science (589 citations), Molecular Biology (2.8k citations), Biomedical Engineering (1.5k citations) and Radiology, Nuclear Medicine and Imaging (781 citations). G. Storm has collaborated with scholars based in Netherlands, Germany and Singapore. Frequent co-authors include Wim E. Hennink, Twan Lammers, Daan J.A. Crommelin, Christien Oussoren, Fabian Kießling, Silvio Aime, Raymond M. Schiffelers, Otto C. Boerman, Wim J.G. Oyen and J. Zuidema. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Controlled Release, Biochimica et Biophysica Acta (BBA) - Biomembranes, Journal of Liposome Research and Advanced Drug Delivery Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.